Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to VCEL. [ FAQ on what and how to ask] For non-VCEL questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 25 Blue Sky Drive, Burlington, MA, United States, 01803
Employees: 398
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
CEO, President & Director
CFO & Treasurer
Chief Operating Officer
Chief Legal Officer
Chief Medical Officer
Principal Accounting Officer, VP & Corporate Controller
Vice President of Finance & Investor Relations
Chief Marketing Officer
Senior Vice President of Corporate Development & Strategy
Senior Vice President of Sales
My Watchlist
